PetPace can enhance the management of A-Fib in dogs by monitoring key indicators such as increased pulse rate, decreased HRV, and changes in activity and posture routines, enabling early detection and personalized care.
What is Atrial Fibrillation (A-fib) and how does it manifest in dogs?
A-fib is a type of arrhythmia characterized by uncontrollable twitching of the heart muscle, particularly the atria. Symptoms may include exercise intolerance, coughing, fast or labored breathing, restlessness, and decreased appetite.
Which dog breeds are more susceptible to A-fib?
A-fib typically appears in large breeds like Irish Wolfhound, Great Dane, Newfoundland, Doberman Pinscher, Boxer, and German Shepherd.
How common are heart diseases in dogs, and what is their treatment approach?
More than 10% of pets have some form of heart disease. Treatment aims to slow down progression and maintain a high quality of life.
Can A-fib be congenital or acquired in dogs?
A-fib, like other heart diseases, can be both congenital (present at birth) or acquired (developed over time).
How can PetPace technology assist in managing A-fib in dogs?
PetPace monitors key indicators such as increased pulse rate, decreased HRV, increased respiratory rate, decreased activity score, changes in posture routine, decreased Wellness score, and deviations from the Health Profile, facilitating early detection and personalized disease management.
What is the goal of A-fib treatment in dogs?
The goal is to manage A-fib effectively, providing a high quality of life for dogs. PetPace’s real-time monitoring aids in assessing treatment effectiveness.
How often should PetPace be used for dogs with A-fib?
Regular use of PetPace is recommended for continuous monitoring, offering a comprehensive view of a dog’s cardiovascular health and ensuring timely adjustments in the management plan.